1. Home
  2. AVBP vs PNTG Comparison

AVBP vs PNTG Comparison

Compare AVBP & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • PNTG
  • Stock Information
  • Founded
  • AVBP 2021
  • PNTG 2019
  • Country
  • AVBP United States
  • PNTG United States
  • Employees
  • AVBP N/A
  • PNTG N/A
  • Industry
  • AVBP
  • PNTG Medical/Nursing Services
  • Sector
  • AVBP
  • PNTG Health Care
  • Exchange
  • AVBP NYSE
  • PNTG Nasdaq
  • Market Cap
  • AVBP 862.8M
  • PNTG 805.7M
  • IPO Year
  • AVBP 2024
  • PNTG N/A
  • Fundamental
  • Price
  • AVBP $21.63
  • PNTG $25.51
  • Analyst Decision
  • AVBP Strong Buy
  • PNTG Buy
  • Analyst Count
  • AVBP 8
  • PNTG 6
  • Target Price
  • AVBP $38.38
  • PNTG $35.17
  • AVG Volume (30 Days)
  • AVBP 484.4K
  • PNTG 286.8K
  • Earning Date
  • AVBP 08-13-2025
  • PNTG 08-05-2025
  • Dividend Yield
  • AVBP N/A
  • PNTG N/A
  • EPS Growth
  • AVBP N/A
  • PNTG 40.99
  • EPS
  • AVBP N/A
  • PNTG 0.76
  • Revenue
  • AVBP N/A
  • PNTG $748,167,000.00
  • Revenue This Year
  • AVBP $85.82
  • PNTG $25.01
  • Revenue Next Year
  • AVBP N/A
  • PNTG $8.19
  • P/E Ratio
  • AVBP N/A
  • PNTG $33.12
  • Revenue Growth
  • AVBP N/A
  • PNTG 30.04
  • 52 Week Low
  • AVBP $15.47
  • PNTG $21.18
  • 52 Week High
  • AVBP $36.37
  • PNTG $37.13
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 47.74
  • PNTG 35.33
  • Support Level
  • AVBP $19.71
  • PNTG $25.50
  • Resistance Level
  • AVBP $22.32
  • PNTG $26.53
  • Average True Range (ATR)
  • AVBP 1.32
  • PNTG 1.07
  • MACD
  • AVBP -0.20
  • PNTG -0.32
  • Stochastic Oscillator
  • AVBP 31.89
  • PNTG 6.32

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: